| 缩写名/全名 |
EXPERT REV ANTICANC
Expert Review of Anticancer Therapy |
||||||||||||||||||||
| ISSN号 | 1473-7140 | ||||||||||||||||||||
| 研究方向 | 医学-肿瘤学 | ||||||||||||||||||||
| 影响因子 | 2015:2.094, 2016:2.212, 2017:2.347, 2018:2.571, 2019:3.573, | ||||||||||||||||||||
| 出版国家 | ENGLAND | ||||||||||||||||||||
| 出版周期 | Bimonthly | ||||||||||||||||||||
| 年文章数 | 83 | ||||||||||||||||||||
| 出版年份 | 2001 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | 偏慢,4-8周 |
||||||||||||||||||||
| 录用比例 | 容易 | ||||||||||||||||||||
| 投稿链接 | https://mc.manuscriptcentral.com/ert | ||||||||||||||||||||
| 投稿官网 | http://www.tandfonline.com/toc/iery20/current#.V48dKEz9cSQ | ||||||||||||||||||||
| h-index | 59 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1473-7140%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | L1 cell adhesion molecule as a therapeutic target in cancer. Author: Yu X, Yang F, Fu DL, Jin C. Journal: Expert Rev Anticancer Ther. 2016;16(3):359-71. doi: 10.1586/14737140.2016.1143363. Epub 2016 Feb 6. PubMed |
| 2. | Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities. Author: Chen H, Wang S, Zhang H, Nice EC, Huang C. Journal: Expert Rev Anticancer Ther. 2016 Jul 5:1-12. [Epub ahead of print] PubMed |
| 3. | Therapeutic potential of irreversible electroporation in sarcoma. Author: Yu Z, Zhang X, Ren P, Zhang M, Qian J. Journal: Expert Rev Anticancer Ther. 2012 Feb;12(2):177-84. doi: 10.1586/era.11.211. PubMed |
| 4. | Circulating microRNAs in cancer: diagnostic and prognostic significance. Author: Zhou L, Zhao YP, Liu WJ, Dong J, Chen WY, Zhang TP, Chen G, Shu H. Journal: Expert Rev Anticancer Ther. 2012 Feb;12(2):283-8. doi: 10.1586/era.11.197. PubMed |
|
|
